A group made up of 13 drugmakers, governments, the Bill & Melinda Gates Foundation and several global health groups made a $785 million commitment toward fighting neglected tropical diseases. Meanwhile, some U.S. lawmakers announced legislation aimed at expediting the development and approval of treatments for chronic diseases. FULL STORY »
By Maureen McKinney | February 03, 2012
| Basic Web
Telecommunications giant Telus expanded its reach into Canada's healthcare information technology market after its healthcare division, Telus Health Solutions, announced it had acquired Wolf Medical Systems, a Canadian IT vendor that specializes in cloud-based electronic health-record systems for physician practices. Terms of the deal were not disclosed. FULL STORY »
The Food and Drug Administration needs more resources for oversight of products developed and manufactured overseas, FDA Commissioner Dr. Margaret Hamburg said during a House hearing examining the Prescription Drug User Fee Act. FULL STORY »
McKesson Corp., San Francisco, has signed a definitive agreement to buy two business units and joint ownership of a pharmacy software program from the Katz Group, a privately owned drugstore operator based in Edmonton, Alberta, Canada. FULL STORY »
Police in pre-dawn sweeps arrested two top former executives of the now-defunct French company at the center of a breast implant scandal affecting tens of thousands of women worldwide. FULL STORY »
IMS Health has acquired PharmARC Analytic Solutions, a Bangalore, India-based provider of commercial analytics and services to drug and medical products companies. FULL STORY »
The Cleveland Clinic said it signed an affiliation agreement with Healthcare Development Holding Co., a professional managed healthcare company in Saudi Arabia, to provide medical education and training to healthcare providers in Saudi Arabia. FULL STORY »
By Modern Healthcare | January 21, 2012
| Print Magazine
SAN ANTONIO—Christus Santa Rosa Hospital-Alamo Heights, a short-stay surgical hospital, opened Jan. 16 after an open house and blessing ceremony on Jan. 13. FULL STORY »
European and U.S. regulators are reviewing Novartis’ Gilenya pill for multiple sclerosis after reports of 11 deaths among patients who took the drug. FULL STORY »
No other country in the world can beat the U.S. in medical technology. No other country spends as much for it either.The mantra "Americans have the best medical care in the world" is frequently recited by U.S. policymakers and clinicians, according to a study published in the May/June issue of the journal Health Affairs that compares the quality of care in five English-speaking countries. But international data--limited though it is--places the U.S. in the bottom quartile of industrialized countries in terms of life expectancy and infant mortality, according to the report.The best... FULL STORY »
